Jialyu Huang

Dr. Jialyu Huang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2024 in Science Advances
Verified
Journal Article
Open access
BDBo Deng
Bo Deng
YMYue Ma
Yue Ma
JHJialyu Huang
Jialyu Huang
RHRunbang He
Runbang He
MLMiaomiao Luo
Miaomiao Luo
PHPengyu Huang
Pengyu Huang
The utilization of three-dimensional (3D) bioprinting technology to create a transplantable bioartificial liver emerges as a promising remedy for the scarcity of liver donors. This study outlines our strategy for constructing a 3D-bioprinted liver, using in vitro–expanded primary hepatocytes recognized for their safety and enhanced functional robustness as hepatic cell sources for bioartificial liver construction. In addition, we have developed bioink biomaterials with mechanical and rheological properties, as well as printing capabilities, tailored for 3D bioprinting. Upon heterotopic transplantation into the mesentery of tyrosinemia or 90% hepatectomy mice, our 3D-bioprinted liver effectively restored lost liver functions, consequently extending the life span of mice afflicted with liver injuries. Notably, the inclusion of an artificial blood vessel in our 3D-bioprinted liver allowed for biomolecule exchange with host blood vessels, demonstrating, in principle, the rapid integration of the bioartificial liver into the host vascular system. This model underscores the therapeutic potential of transplantation for the treatment of liver failure diseases.

10 December 2019 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
JLJiaying Lin
Jiaying Lin
JHJialyu Huang
Jialyu Huang
NWNingling Wang
Ningling Wang
Yanping KuangYanping Kuang
Yanping Kuang
RCRenfei Cai
Renfei Cai
Background: Previous studies have shown that among women with polycystic ovary syndrome who have difficulties conceiving, frozen-embryo transfer resulted in increased live birth rates and decreased ovarian hyperstimulation syndrome risk than did fresh-embryo transfer. In the present retrospective analysis, we sought to determine the effect of body mass index (BMI) on pregnancy and perinatal outcomes in women with PCOS undergoing FET.Methods: Women with PCOS (n = 1556) undergoing FET were divided into groups based on weight, with those with normal weight having a BMI of 18.5–24.9 kg/m2,those who were overweight having a BMI of 25–29.9 kg/m2, and those who were obese having a BMI ≥30 kg/m2. Both pregnancy and perinatal outcomes were compared among these groups.Results: The normal-weight, overweight, or obese groups exhibited similar pregnancy outcomes, including clinical pregnancy rate, miscarriage rate, ongoing pregnancy rate and live birth rate. In singletons, birth characteristics regarding newborn gender, gestational age, birthweight and length at birth were comparable between the three groups. For adverse neonatal outcomes, the three groups showed no significant differences on the rates of low birthweight, very low birthweight, preterm birth, and very preterm birth after adjustment. In addition, the obstetric complications and the frequencies of live-birth defects were also comparable between the three groups except that overweight and obese women were more likely than women of normal weight to have delivered via cesarean section.Conclusion: BMI did not affect the pregnancy or perinatal outcomes in women with PCOS undergoing FET.

11 March 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
LTLifeng Tian
Lifeng Tian
LXLeizhen Xia
Leizhen Xia
HLHongbo Liu
Hongbo Liu
YKYan Kou
Yan Kou
ZHZhihui Huang
Zhihui Huang
QWQiongfang Wu
Qiongfang Wu
Purpose: To study the relationship between blastomere number and pregnancy outcomes of day 3 embryo transfers. Methods: This retrospective cohort study included 2237 fresh single day 3 embryo transfer cycles from October 2013 to November 2020. Patients were divided into six groups according to the blastomere number on day 3: ≤ 6-cell (n = 100), 7-cell (n = 207), 8-cell (n = 1522), 9-cell (n = 187), 10-cell (n = 91) and ≥ 11-cell (n = 130). Generalized estimating equation analysis based on multivariate logistic regression model was performed to adjust for potential confounders. Results: The live birth rate (LBR) was 19.0%, 27.1%, 38.9%, 32.1%, 44.0% and 53.8% for the ≤ 6-cell, 7-cell, 8-cell, 9-cell, 10-cell and ≥ 11-cell groups, respectively (P < 0.001). Specifically, the ≤ 6-cell group was associated with reduced LBR compared with the 8-cell group (aOR 0.50, 95% CI 0.29–0.86; P = 0.013). Conversely, the odds of live birth were significantly increased in patients transferred with 10-cell embryos (aOR 1.62, 95% CI 1.03–2.53; P = 0.035) and ≥ 11-cell embryos (aOR 2.14, 95% CI 1.47–3.11; P < 0.001) when using the 8-cell embryo group as reference. Similar trends were also observed in the rates of positive hCG test and clinical pregnancy, while no significant differences were detected in miscarriage risk. Conclusion: Increased blastomere number was associated with higher LBR in fresh single day 3 embryo transfer cycles. This finding questions the consensus on the reduced developmental potential of fast-cleaving embryos. Further large prospective studies are warranted for confirmation.

13 June 2023 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
ZFZheng Fang
Zheng Fang
JHJialyu Huang
Jialyu Huang
JMJiaqin Mao
Jiaqin Mao
LYLamei Yu
Lamei Yu
XWXiaohong Wang
Xiaohong Wang
Purpose: This systematic review and meta-analysis aimed to explore the relationship of endometrial thickness (EMT) with obstetric and neonatal outcomes in assisted reproductive cycles. Methods: PubMed, EMBASE, Cochrane Library and Web of Science were searched for eligible studies through April 2023. Obstetric outcomes include placenta previa, placental abruption, hypertensive disorders of pregnancy (HDP), gestational diabetes mellitus (GDM) and cesarean section (CS). Neonatal outcomes include birthweight, low birth weight (LBW), gestational age (GA), preterm birth (PTB), small for gestational age (SGA) and large for gestational age (LGA). The effect size was estimated as odds ratio (OR) or mean difference (MD) with 95% confidence interval (CI) using a random-effects model. Inter-study heterogeneity was assessed by the chi-square homogeneity test. One-study removal method was used to determine the sensitivity of the meta-analysis. Results: Nineteen studies involving 76,404 cycles were included. The pooled results revealed significant differences between the thin endometrium group and the normal group in placental abruption (OR = 2.45, 95% CI: 1.11–5.38, P = 0.03; I2 = 0%), HDP (OR = 1.72, 95% CI: 1.44–2.05, P < 0.0001; I2 = 0%), CS (OR = 1.33, 95% CI: 1.06–1.67, P = 0.01; I2 = 77%), GA (MD = -1.27 day, 95% CI: -2.41– -1.02, P = 0.03; I2 = 73%), PTB (OR = 1.56, 95% CI: 1.34–1.81, P < 0.0001; I2 = 33%), birthweight (MD = -78.88 g, 95% CI: -115.79– -41.98, P < 0.0001; I2 = 48%), LBW (OR = 1.84, 95% CI: 1.52–2.22, P < 0.00001; I2 = 3%) and SGA (OR = 1.41, 95% CI: 1.17–1.70, P = 0.0003; I2 = 15%). No statistical differences were found in placenta previa, GDM, and LGA. Conclusion: Thin endometrium was associated with lower birthweight or GA and higher risks of placental abruption, HDP, CS, PTB, LBW and SGA. Therefore, these pregnancies need special attention and close follow-up by obstetricians. Due to the limited number of included studies, further studies are needed to confirm the results.

21 January 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
BYBin Yang
Bin Yang
LXLeizhen Xia
Leizhen Xia
RDRufei Deng
Rufei Deng
LWLiping Wu
Liping Wu
ZZZhiqin Zhang
Zhiqin Zhang
ZHZhihui Huang
Zhihui Huang
Background: The role of sperm DNA fragmentation index (DFI) in fertility remains controversial. Herein, we analyzed its association with semen parameters, embryonic development, and pregnancy outcomes after in vitro fertilization (IVF) treatment. Additionally, we assessed whether DFI had a potential impact on long-term maternal and neonatal complications.Methods: A total of 5,271 women who underwent IVF treatment for the first time between October 1, 2020, and July 31, 2023, were included from an academic fertility center. Participants were categorized into three groups based on sperm DFI: DFI < 15%, 15 ≤ DFI < 30%, and DFI ≥ 30%. We collected data on patient demographics, semen parameters, embryonic development, clinical outcomes, maternal and infant complications. Multivariate logistic regression analyses were conducted to control for potential confounders.Results: The DFI value was negatively correlated with semen quality in males. High DFI affected the blastocyst formation rate (56.44%, 55.32%, 53.72%, respectively; P=0.045) and the rate of transferable embryos (3.97 ± 2.71, 3.90 ± 2.7, 3.38 ± 2.4, respectively; P<0.001); however, no significant difference in pregnancy outcomes was observed among the three groups. Elevated DFI did not contribute to clinically relevant adverse maternal events during pregnancy, but it was associated with an increased risk of low birth weight (3.9%, 6.6%, 10.1%, respectively; P=0.006) in newborns.Conclusions: Sperm DFI could influence embryonic development, with a higher risk of low birthweight infants in the high DFI group. However, it does not appear to affect clinical outcomes or other perinatal complications. The role of DFI as a predictive factor in assisted reproduction, especially regarding offspring outcomes, requires further investigation with larger sample sizes.

2 March 2024 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
YZYunxiao Zhao
Yunxiao Zhao
JWJiawei Wang
Jiawei Wang
WQWeili Qin
Weili Qin
QHQianwen Hu
Qianwen Hu
JLJiaxu Li
Jiaxu Li
AQAiping Qin
Aiping Qin